Glycopyrrolate Injection
Product Images NDC 43547-543

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 43547-543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A7286439-figure-01 (A7286439 Figure 01)

Chemical structure of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

Container Label For 0.2 mg/ml (A7286439 Figure 02)

Glycopyrrolate Injection, USP 0.2 mg/mL in a single-dose vial, labeled for intramuscular and intravenous administration. The label indicates storage conditions at 20° to 25°C (68° to 77°F) and notes usage directions referencing typical dosage instructions. Manufactured by Solco Healthcare US, LLC, the label includes standard drug information and lot identification details.*

FDA Label Image

Container Label For 0.4 mg/2 mL (A7286439 Figure 03)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) by Solco Healthcare US, LLC. The label indicates intramuscular or intravenous administration, packaging of 25 single-dose 2 mL vials, with storage instructions at 20°C to 25°C. Manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., China, and distributed by Solco Healthcare US.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.